Skip Navigation

For U.S. Healthcare Professionals

Patient.

Dosing
& Administration

Consistent &
Predictable
Dosing1

Healthcare professional.

For adult patients with moderately to severely active UC or CD when other therapies have not worked well enough or cannot be tolerated.

SIMPLE DOSING FOR YOUR PATIENTS WITH UC OR CD1

Entyvio offers your patients consistent, predictable dosing1

STARTING & MAINTAINING TREATMENT

HOW TO START

Start with infusions at Weeks 0, 2, and 6

Infusion Week 0.
Infusion Week 2.
Infusion Week 6.

HOW TO MAINTAIN

Continue every 8 weeks thereafter

Infusion Q8W.

Discontinue therapy in patients who show no
evidence of therapeutic benefit by Week 14

After 1 year, a patient will receive 6 maintenance doses per year, with a total annual infusion time of approximately 3 hours.1

DOSING & ADMINISTRATION INFORMATION

Infusion bag icon.

ADMINISTRATION

  • Administered as a 300 mg flat dose over an approximately 30‑minute IV infusion1
  • A total of 6 maintenance doses annually after the first year1
  • Do not administer as an IV push or bolus
Monitoring icon.

MONITORING

  • Entyvio IV should be administered by a healthcare professional prepared to manage hypersensitivity reactions, including anaphylaxis, if they occur. Appropriate monitoring and medical support measures should be available for immediate use. Observe patients during infusion and until the infusion is complete1
Rx icon.

CONCOMITANT THERAPIES

  • Entyvio can be administered concomitantly with aminosalicylates, steroids, or immunomodulators1
Clipboard icon.

PRIOR TO ADMINISTRATION

  • Patients should be brought up to date with all immunizations prior to starting Entyvio1

For complete dosage and administration information, please see full Prescribing Information.

Starting and Maintaining Treatment

DOSING & ADMINISTRATION VIDEO

For demonstrative purposes only.
Please see full Prescribing Information for complete reconstitution and dilution instructions.

Get your patients started with
EntyvioConnect

LEARN MORE

Find helpful resources
for your practice & your patients

FIND OUT MORE

Reference:

  1. Entyvio (vedolizumab) prescribing information. Takeda Pharmaceuticals.